Search research articles

关于 JoVE

概览领导团队博客 JoVE 帮助中心

作者

出版流程编辑委员会范围与政策同行评审常见问题投稿

图书馆员

用户评价订阅访问资源图书馆顾问委员会常见问题

研究

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments 存档

教育

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual 教师资源中心教师网站

使用条款与条件

相关概念视频

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序

Same author

Outcomes Following Targeted Muscle Reinnervation in Pediatric Amputations: A Systematic Review.

Plastic and reconstructive surgery. Global open·2026

Same author

Glucagon-Like Peptide-1 Receptor Agonists in Hip and Knee Arthroplasty: A Comprehensive Systematic Review and Meta-Analysis of Perioperative and Postoperative Outcomes.

Arthroplasty today·2026

Same author

CARMN fusions and PDGFRB mutations highlight key differences among cutaneous tumors with myopericytic differentiation.

The Journal of investigative dermatology·2026

Same author

Approche de la douleur chronique au poignet chez les adultes: Revue des pathologies courantes à l'intention des praticiens des soins primaires.

Canadian family physician Medecin de famille canadien·2026

Same author

Elective Surgical Care Pathways Are Associated With Lower Fracture Rates at Presentation and Contribute to Superior Clinical Outcomes in Metastatic Bone Disease.

Journal of surgical oncology·2026

Same author

Updates in Skin Adnexal Tumors.

Dermatologic clinics·2026

Search research articles

相关实验视频

Updated: Jun 17, 2025

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

聪明地使用名图:预测黑色素瘤中的哨兵节点阳性

Priscila Rojas-Garcia^1,2, Bryan Ma³, Eva Lindell Jonsson^1,2

¹Department of Surgery, Tom Baker Cancer Centre, Calgary, AB, Canada.

Annals of surgical oncology

|August 14, 2024

概括

此摘要是机器生成的。

不同的黑色素瘤预测名录产生不同的哨兵淋巴结活检 (SNB) 风险得分. 淋巴血管侵入等因素显著影响这些预测,突出了风险估计工具的敏感性.

关键词:

淋巴结的风险淋巴结的风险黑色色素瘤 (Mlanoma) 是一种多色素瘤.诺莫格拉姆斯 (Nomograms) 是一个名字.哨兵淋巴结活组织检查一个阶段,一个阶段.

更多相关视频

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

Predictive Immune Modeling of Solid Tumors

Predictive Immune Modeling of Solid Tumors

Published on: February 25, 2020

相关实验视频

Last Updated: Jun 17, 2025

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

Predictive Immune Modeling of Solid Tumors

Predictive Immune Modeling of Solid Tumors

Published on: February 25, 2020

科学领域:

在瘤学瘤学.
皮肤病学皮肤病学
手术病理学手术病理学

背景情况:

存在多种经过验证的诺姆图,用于预测恶性黑色素瘤中哨兵结节活检 (SNB) 风险.
这些名图利用了不同的临床和组织病理学因素,导致患者风险分层的潜在差异.
本研究调查了不同SNB预测模型中风险估计的变化.

研究的目的:

为了比较MSKCC和MIA为恶性黑色素瘤中哨戒结活检提供的风险估计,我们使用了Nomograms.
识别关键的组织病理学变量,这些变量有助于在nomograms之间风险预测的显著差异.

主要方法:

使用随机数发生器生成300个具有不同临床和病理特征的假设薄黑色素瘤病例.
在MSKCC和MIA nomograms之间的风险预测的比较.
应用千二测试和多变量线性回归来分析预测差异并确定影响因素.

主要成果:

与MIA名录相比,MSKCC名录通常预测的风险较低 (p < 0.001).
显著更高的比例的患者预测风险超过15%的MIA名录 (43%) 与MSKCC名录 (0.7%).
淋巴血管侵袭 (LVI),线粒发育和黑色素瘤亚型被确定为驱动预测差异 (>10%) 的关键因素.

结论:

诺米图对于预测黑色素瘤患者SNB风险非常有价值.
纳米图中包含的预测因素的选择显著影响了由此产生的风险输出,强调了这些工具的敏感性.